Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Botzenhardt

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|April 17, 1977
[Inhibition of the humural immune response by B-cells]B Stockinger, U Botzenhardt, E M Lemmel
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1975
[Radioimmunologic determination of anti-DNA antibodies in lupus erythematosus]B Heicke, E M Lemmel, U Botzenhardt
Langenbecks Archiv Fur Chirurgie|January 1, 1976
[Immunopathological genesis of pancreatitides]M Neher, E M Lemmel, U Botzenhardt
Rheumatology International|January 1, 1984
Equal distribution of T-lymphocyte subpopulations in thymus and spleen cells of NZB and BALB/c miceJ Müller-Quernheim, U Botzenhardt, D von Steldern
Immunobiology|July 1, 1983
Primary in vivo T cell reactivity of NZB grafts in H-2 identical allogenic hostsU Botzenhardt, J Siegmund, V Siegmund, et al.
International Archives of Occupational and Environmental Health|January 1, 1986
Lymphocyte subpopulations in solvent-exposed workersW Denkhaus, D von Steldern, U Botzenhardt, et al.
Blut|June 1, 1982
Studies on the mechanism of PMN activation. I. By dextran sulfatesJ Müller, U Botzenhardt, P Alföldy, et al.
International Archives of Allergy and Applied Immunology|January 1, 1988
Increased helper cell activity of NZB mice against H-2-identical allogeneic cellsJ Müller-Quernheim, U Botzenhardt, D von Steldern, et al.
Leukemia|June 25, 2011
Deregulated apoptosis signaling in core-binding factor leukemia differentiates clinically relevant, molecular marker-independent subgroupsS C Lück, A C Russ, U Botzenhardt, et al.
Leukemia|March 29, 2014
Leukemic stem cells of acute myeloid leukemia patients carrying NPM1 mutation are candidates for targeted immunotherapyV Schneider, L Zhang, L Bullinger, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|April 17, 1977
[Inhibition of the humural immune response by B-cells]B Stockinger, U Botzenhardt, E M Lemmel
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1975
[Radioimmunologic determination of anti-DNA antibodies in lupus erythematosus]B Heicke, E M Lemmel, U Botzenhardt
Langenbecks Archiv Fur Chirurgie|January 1, 1976
[Immunopathological genesis of pancreatitides]M Neher, E M Lemmel, U Botzenhardt
Rheumatology International|January 1, 1984
Equal distribution of T-lymphocyte subpopulations in thymus and spleen cells of NZB and BALB/c miceJ Müller-Quernheim, U Botzenhardt, D von Steldern
Immunobiology|July 1, 1983
Primary in vivo T cell reactivity of NZB grafts in H-2 identical allogenic hostsU Botzenhardt, J Siegmund, V Siegmund, et al.
International Archives of Occupational and Environmental Health|January 1, 1986
Lymphocyte subpopulations in solvent-exposed workersW Denkhaus, D von Steldern, U Botzenhardt, et al.
Blut|June 1, 1982
Studies on the mechanism of PMN activation. I. By dextran sulfatesJ Müller, U Botzenhardt, P Alföldy, et al.
International Archives of Allergy and Applied Immunology|January 1, 1988
Increased helper cell activity of NZB mice against H-2-identical allogeneic cellsJ Müller-Quernheim, U Botzenhardt, D von Steldern, et al.
Leukemia|June 25, 2011
Deregulated apoptosis signaling in core-binding factor leukemia differentiates clinically relevant, molecular marker-independent subgroupsS C Lück, A C Russ, U Botzenhardt, et al.
Leukemia|March 29, 2014
Leukemic stem cells of acute myeloid leukemia patients carrying NPM1 mutation are candidates for targeted immunotherapyV Schneider, L Zhang, L Bullinger, et al.
Pageof 4